A disagreement between Gilead and the World Health Organization over the…
The “New York Times” newspaper says that the announcement by health officials in Jiaxing, Thursday, sheds light on how China has expanded its mass vaccination campaign even before the end of the strict tests.
The move baffled many scientists who indicated that the outbreak in China had been under control for months, according to “The New York Times”.
The local Center for Disease Control and Prevention said Thursday that the vaccine, developed by the private Chinese company Sinovac Biotec, is being provided on an “emergency use” basis in Jiaxing.
He added that workers in relatively high-risk jobs, including medical workers, customs inspectors and public servants, would have priority to receive the “emergency vaccine.”
According to the center, after that, the vaccine will be provided to ordinary citizens by reservation at the vaccination sites at the city level.
Two doses will be provided to people between the ages of 18 and 59 for approximately $ 60, and they will be given over a period of 14 to 28 days.
Since July, Chinese vaccine manufacturers have vaccinated tens of thousands of employees of state-owned companies, government officials and vaccine company executives.
The Chinese government has indicated, in recent weeks, that it will expand the campaign to include teachers, travelers and shop workers.